Avanir Captures The Alamo; Acquisition Will Give Avanir FazaClo
This article was originally published in The Pink Sheet Daily
Executive Summary
Acquisition of the schizophrenia therapy FazaClo will complement Avanir’s Neurodex, which is under review at FDA.